Freeline Presents Positive New Data from Phase 1/2 GALILEO-1 Trial of FLT201, Its Novel Gene Therapy Candidate, in Gaucher Disease at ESGCT 30th Annual Congress
Plugin JSON Content Importer Pro not running: Check Licence! Check that a Licence is active for https://freeline.life